en
Scientific article
Review
French

Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Other title[How to deal with an unexpected event that could alter the normal activity of cellular therapy? Recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]
Published inBulletin du cancer, vol. 108, no. 12S, p. S20-S25
Publication date2021-12
First online date2021-06-30
Abstract

The SARS-CoV-2 (COVID-19) pandemic has rapidly impacted cell therapy activities across the globe. Not only was this, unexpected event, a threat to patients who had previously received hematopoietic cell transplantation or other cell therapy such as CAR-T cells, but also, it was responsible for a disruption of cell therapy activities due to the danger of the virus and to the lack of solid scientific data on the management of patients and donors. The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) devoted a workshop to issue useful recommendations in such an unexpected event in order to harmonize the actions of all the actors involved in cellular therapy programs so that we can collectively face, in the future, the challenges that could threaten our patients. This work is not specifically dedicated to the SARS-CoV-2 outbreak, but the latter has been used as a concrete example of an unexpected event to build up our recommendations.

eng
Keywords
  • Bone Marrow Transplantation / standards*
  • COVID-19 / epidemiology*
  • Cell Transplantation / standards*
  • Cryopreservation
  • Health Services Accessibility
  • Hematopoietic Stem Cell Transplantation / standards
  • Humans
  • Immunotherapy, Adoptive / standards
  • Pandemics*
  • Receptors, Chimeric Antigen / therapeutic use
  • Societies, Medical
  • Tissue Donors
Citation (ISO format)
BAY, Jacques Olivier et al. Comment faire face à un événement inattendu pouvant modifier l’activité normale de thérapie cellulaire ? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). In: Bulletin du cancer, 2021, vol. 108, n° 12S, p. S20–S25. doi: 10.1016/j.bulcan.2021.05.002
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal0007-4551
155views
0downloads

Technical informations

Creation10/21/2021 8:14:00 AM
First validation10/21/2021 8:14:00 AM
Update time03/16/2023 6:28:33 AM
Status update03/16/2023 6:28:32 AM
Last indexation02/12/2024 12:22:25 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack